LOW-FREQUENCY ASSOCIATION OF THE T(2-5)(P23-Q35) CHROMOSOMAL TRANSLOCATION WITH CD30(- A REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION STUDY() LYMPHOMAS FROM AMERICAN AND ASIAN PATIENTS )
Jr. Lopategui et al., LOW-FREQUENCY ASSOCIATION OF THE T(2-5)(P23-Q35) CHROMOSOMAL TRANSLOCATION WITH CD30(- A REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION STUDY() LYMPHOMAS FROM AMERICAN AND ASIAN PATIENTS ), The American journal of pathology, 146(2), 1995, pp. 323-328
Although cytogenetic data suggest that the t(2;5)-(p23;q35) translocat
ion occurs in many cases of CD30(+) lymphomas, the exact frequency of
this event is still unknown. To clarify this issue and its epidemiolog
ical characteristics, we examined 37 formalin-fixed, paraffin-embedded
specimens of CD30(+) lymphomas from the United States and Hong Kong b
y reverse transcriptase-polymerase chain reaction (RT-PCR) for the sta
tus of the NPM and ALK genes, which are typically juxtaposed by the t(
2;5) translocation. Thirty-four cases were classified as anaplastic la
rge cell lymphomas (ALCL), 2 cases as non-anaplastic large cell lympho
mas (LCL), and 1 case as the small cell variant of CD30(+) lymphoma. T
he t(2;5) translocation was defected in 6 cases (16%), including 3 of
18 American patients and 3 of 13 cases from Hong Kong. All cases had a
185-bp NPM RT-PCR product as detected by Southern blot analysis, indi
cating adequate preservation of mRNA. The 6 positive cases were among
4 of 34 adult lymphomas, as compared with 2 of 3 childhood cases. Five
of 17 T-lineage cases were t(2;5)-positive, compared with 1 of 15 B-l
ineage cases and none of the 5 null-cell or mixed lineage cases. Our r
esults therefore show that t(2;5) occurs at a low frequency among CD30
(+) lymphomas, at least in our adult-dominated series.